Evaluation of the proper dosage of lapatinib and its safety in dogs
Lapatinib is a low-molecular-weight agent targeting the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). It is one of the antitumor agents used against advanced breast cancer in human. We intended to apply it against canine mammary gland tumors (cMGTs). To...
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Tokyo Metropolitan Institute of Medical Science
2020
|
| Acesso em linha: | http://psasir.upm.edu.my/id/eprint/88878/1/DOG.pdf |